The behavioral effects of felbamate were assessed in 20 persons (ages 2 to 19 years) who were participating in a compassionate plea protocol for children with Lennox-Gastaut syndrome. Parents completed a questionnaire concerning aspects of behavioral change once all medications were in a constant regimen. Significant improvements were suggested in social functioning, intellectual functioning, motor functioning, attention and concentration, alertness, initiative, variability In performance, and memory. There was a tendency for these effects to reverse when the drug was discontinued.
References
1.
Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). New England Journal of Medicine, 1993, 328, 29–33.
2.
LeppikI. E.GravesN. M.Potential antiepileptic drugs: felbamate. In LevyR. H.DreifussF. E.MattsonR. H.MeldrumB. S.PenryJ. K. (Eds.), Antiepileptic drugs. (3rd ed.) New York: Raven, 1989. Pp. 983–990.
3.
NeidermeyerE.DegenR.The Lennox-Gastaut Syndrome. New York: Liss, 1988.
